ENTX
Price
$2.84
Change
+$0.05 (+1.79%)
Updated
Sep 11 closing price
Capitalization
489.13M
54 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$12.51
Change
-$0.67 (-5.08%)
Updated
Sep 11 closing price
Capitalization
1.06B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENTX vs MLTX

ENTX vs MLTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ENTX vs. MLTX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Hold and MLTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.06B) has a higher market cap than ENTX($489M). ENTX YTD gains are higher at: 46.392 vs. MLTX (-5.083). ENTX has higher annual earnings (EBITDA): -14.37M vs. MLTX (-250.82M). MLTX has more cash in the bank: 537M vs. ENTX (11.3M). ENTX has less debt than MLTX: ENTX (425K) vs MLTX (102M). ENTX (0) and MLTX (0) have equivalent revenues.
ENTXMLTXENTX / MLTX
Capitalization489M1.06B46%
EBITDA-14.37M-250.82M6%
Gain YTD46.392-5.083-913%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.3M537M2%
Total Debt425K102M0%
FUNDAMENTALS RATINGS
ENTX vs MLTX: Fundamental Ratings
ENTX
MLTX
OUTLOOK RATING
1..100
3055
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3587
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLTX's Valuation (22) in the null industry is somewhat better than the same rating for ENTX (86) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew somewhat faster than ENTX’s over the last 12 months.

MLTX's Profit vs Risk Rating (95) in the null industry is in the same range as ENTX (100) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew similarly to ENTX’s over the last 12 months.

MLTX's SMR Rating (98) in the null industry is in the same range as ENTX (99) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew similarly to ENTX’s over the last 12 months.

ENTX's Price Growth Rating (35) in the Pharmaceuticals Major industry is somewhat better than the same rating for MLTX (87) in the null industry. This means that ENTX’s stock grew somewhat faster than MLTX’s over the last 12 months.

ENTX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as MLTX (100) in the null industry. This means that ENTX’s stock grew similarly to MLTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTXMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (ENTX: $2.84 vs. MLTX: $12.51)
Brand notoriety: ENTX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 11% vs. MLTX: 190%
Market capitalization -- ENTX: $489.13M vs. MLTX: $1.06B
ENTX [@Biotechnology] is valued at $489.13M. MLTX’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green while MLTX’s FA Score has 1 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENTX and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 2 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • ENTX’s TA Score: 2 bullish, 5 bearish.
  • MLTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than ENTX.

Price Growth

ENTX (@Biotechnology) experienced а -5.33% price change this week, while MLTX (@Biotechnology) price change was -16.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ENTX is expected to report earnings on Nov 05, 2026.

MLTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ENTX
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVMX11.990.10
+0.84%
American Century Non-US Intrs ValR6
CWIEX81.780.03
+0.04%
American Funds Cptl Wld Gr&Inc 529-E
SMAPX12.63N/A
N/A
Westwood Salient MLP & Engy Infras A
LFGOX44.23N/A
N/A
Lord Abbett Focused Growth F3
BASMX34.48N/A
N/A
iShares Total US Stock Market Idx Inv A

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-5.08%
KALA - MLTX
82%
Closely correlated
+1.69%
XNCR - MLTX
50%
Loosely correlated
+0.62%
NRIX - MLTX
45%
Loosely correlated
-2.75%
AUPH - MLTX
45%
Loosely correlated
-0.06%
XENE - MLTX
44%
Loosely correlated
-0.26%
More